Mehmet Tolga KAFADAR, Mehmet Ali KIRŞAN, Abdullah OĞUZ

Morbid Obezite Tedavisinde Laparoskopik Sleeve Gastrektominin Metabolik Etkinliği: Tek Merkezin Erken ve Orta Dönem Sonuçları

Amaç: Bu çalışmanın amacı morbid obezitenin önlenebilir metabolik sonuçlarında yapılan laparoskopik sleeve gastrektominin (LSG)etkinliğini ortaya koymaktır. Kliniğimizde ameliyat olan hastaların ameliyat sonrası erken ve orta dönemde vücut kitle indeksine (VKİ)göre kilo kayıplarını, obeziteye eşlik eden komorbid hastalıklardaki değişimlerini, orta dönemde vitamin eksikliğinin olup olmadığınıve ameliyatla ilişkili komplikasyonları değerlendirdik. Yöntemler: Bu çalışmada Dicle Üniversitesi Tıp Fakültesi Genel Cerrahi Kliniği tarafından 1 Ocak 2010- Aralık 2019 tarihleri arasında,morbid obezite nedeniyle LSG girişimi uygulanan 18-60 yaş arası toplam 50 hasta retrospektif olarak değerlendirildi. Hastalarınsosyodemografik verileri ile preoperatif VKİ, postoperatif 3.ay, 6.ay ve 1.yıl VKI değerleri, preoperatif ve postoperatif 12.ay HgA1cdüzeylerine bakıldı. Mortalite ve komplikasyon oranları değerlendirildi. Bulgular: Elli hastanın LSG öncesi, operasyon sonrası 3.ay, 6.ay ve 1.yıl kontrollerindeki ortalama VKİ sırasıyla; 45.83±6.37,37.63±5.88, 31.91±5.10 ve 26.82±3.08kg/m2 olarak bulundu. Girişim öncesine göre, 3.ay, 6.ay ve 1.yıl kontrollerinde VKİ’ndeki düşüşanlamlı idi (p

Metabolic Effectiveness of Laparoscopic Sleeve Gastrectomy inMorbid Obesity Treatment: Early and Mid-Term Results of a SingleCenter

Objective: The aim of this study is to reveal the efficacy of laparoscopic sleeve gastrectomy (LSG) in the preventable metabolic consequences of morbid obesity. We evaluated the weight loss according to body mass index (BMI), changes in comorbid diseasesaccompanying obesity in patients who underwent surgery in our clinic in the early and mid-period postoperatively, whether there was vitamin deficiency in the mid-term, and the complications associated with the surgery.Methods: In this study, a total of 50 patients aged 18-60 who underwent LSG intervention due to morbid obesity between January 1, 2010 and December 2019 by Dicle University School of Medicine, General Surgery Clinic, were retrospectively evaluated. Sociodemographic data of the patients, preoperative BMI, postoperative 3th month, 6th month and 1st year BMI values, preoperative and postoperative 12th month HgA1c levels were measured. Mortality and complication rates were evaluated.Results: The mean BMI of 50 patients at pre-LSG, postoperative 3rd month, 6th month and 1st year controls were respectively; 45.83±6.37, 37.63±5.88, 31.91±5.10 and 26.82±3.08kg/m2. Compared to before the intervention, the decrease in BMI was significant at the 3rd month, 6th month and 1st year controls (p

PDF

___

1. Cummings DE, Rubino F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 2018; 61: 257-64.
2. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017; 376: 641-51.
3. Sethi P, Thillai M, Nain PS, Ahuja A, Aulakh N, Khurana P. Role of Hunger Hormone "Ghrelin" in Long-Term Weight Loss Following Laparoscopic Sleeve Gastrectomy. Niger J Surg. 2018; 24: 121-4.
4. Benaiges D, Más-Lorenzo A, Goday A, et al. Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol. 2015; 21: 11804-14.
5. Sharma G, Nain PS, Sethi P, Ahuja A, Sharma S. Plasma ghrelin levels after laparoscopic sleeve gastrectomy in obese individuals. Indian J Med Res. 2019; 149: 544-7.
6. Su DW, Wei WW, Yao RR, Yang CJ, Tian H. Research on sleeve gastrectomy for the treatment of rats with type 2 diabetes mellitus and the regulation of ghrelin and intestinal lesions. Eur Rev Med Pharmacol Sci. 2020; 24: 10653-62.
7. Mehdar KM, Alsareii SA, Alshafie SEM, Al-Rafiah AR, Alamri AM. Ghrelin gastric tissue expression in patients with morbid obesity and type 2 diabetes submitted to laparoscopic sleeve gastrectomy: immunohistochemical and biochemical study. Folia Histochem Cytobiol. 2020; 58: 235-46.
8. Shantavasinkul PC, Torquati A, Corsino L. Postgastric bypass hypoglycaemia: a review. Clin Endocrinol (Oxf). 2016; 85: 3-9.
9. Albeladi B, Bourbao-Tournois C, Huten N. Shortand midterm results between laparoscopic Roux-enY gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes. 2013; 2013: 934653.
10. Baltasar A, Serra C, Pérez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005; 15: 1124-8.
11. Palermo M, Serra E. Laparoscopic Sleeve Gastrectomy: How Do I Do It. J Laparoendosc Adv Surg Tech A. 2020; 30: 2-5.
12. Mihmanli M, Isil RG, Bozkurt E, et al. Postoperative effects of laparoscopic sleeve gastrectomy in morbid obese patients with type 2 diabetes. Springerplus. 2016; 5: 497.
13. Baştürk S. Sleeve gastrektomi’nin orta ve uzun dönem sonuçları, obeziteye eşlik eden komorbiditelere etkileri, Uzmanlık Tezi, 2015, Denizli.
14. Chang X, Cai H, Yin K. The Regulations and Mechanisms of Laparoscopic Sleeve Gastrectomy (LSG) for Obesity and Type 2 Diabetes: A Systematic Review. Surg Laparosc Endosc Percutan Tech. 2017; 27: e122-e126.
15. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010; 6: 707-13.
16. Heusschen L, Schijns W, Ploeger N, et al. The True Story on Deficiencies After Sleeve Gastrectomy: Results of a Double-Blind RCT. Obes Surg. 2020; 30: 1280-90.
17. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013; 310: 2435-42.
18. Steenackers N, Van der Schueren B, Mertens A, et al. Iron deficiency after bariatric surgery: what is the real problem? Proc Nutr Soc. 2018; 77: 445-55.
19. Sioka E, Tzovaras G, Perivoliotis K, et al. Impact of Laparoscopic Sleeve Gastrectomy on Gastrointestinal Motility. Gastroenterol Res Pract. 2018; 2018: 4135813.
20. Al-Mulhim AS. Laparoscopic Sleeve Gastrectomy and Nutrient Deficiencies: A Prospective Study. Surg Laparosc Endosc Percutan Tech. 2016; 26: 208-11.
21. van Rutte PW, Aarts EO, Smulders JF, Nienhuijs SW. Nutrient deficiencies before and after sleeve gastrectomy. Obes Surg. 2014; 24: 1639-46.
22. Zarshenas N, Nacher M, Loi KW, Jorgensen JO. Investigating Nutritional Deficiencies in a Group of Patients 3 Years Post Laparoscopic Sleeve Gastrectomy. Obes Surg. 2016; 26: 2936-43.
23. Caron M, Hould FS, Lescelleur O, et al. Long-term nutritional impact of sleeve gastrectomy. Surg Obes Relat Dis. 2017; 13: 1664-73.
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-30.
25. Trastulli S, Desiderio J, Guarino S, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013; 9: 816-29.
26. Haskins IN, Nowacki AS, Khorgami Z, et al. Should recent smoking be a contraindication for sleeve gastrectomy? Surg Obes Relat Dis. 2017; 13: 1130-5.